Eyedrop targets Mite-Related dry eye in small study
Disease control
Completed
This study tested an eyedrop called TP-03 in 39 people with dry eye disease caused by Demodex mites. The goal was to see if giving the drops twice or three times a day is safe and works better. The study focused on safety and how well the drops improve signs of the condition.
Phase: PHASE2 • Sponsor: Tarsus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 12:27 UTC